Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (28)
Flavio Requejo, Javier Opezzo, Alan Vater, Marcelo Asprea, Eduardo Lagomarsino, Claudia Sampor, Adriana Fandiño, Guillermo Chantada, Jasmine H. Francis, David H. Abramson & Paula Schaiquevich. (2023) Pharmacokinetics of Orbital Topotecan After Ophthalmic Artery Chemosurgery and Intravenous Infusion in the Swine Model. Investigative Opthalmology & Visual Science 64:12, pages 3.
Crossref
Crossref
Xuyang Wen, Jiayan Fan, Mei Jin, Hua Jiang, Jiakai Li, Minglei Han, Chengyue Zhang, Xiaoyu He, Yingxiu Luo, Jie Yang, Min Zhou, Jia Tan, Xinji Yang, Xunda Ji, Jing Zhang, Junyang Zhao, Renbing Jia & Xianqun Fan. (2023) Intravenous versus super-selected intra-arterial chemotherapy in children with advanced unilateral retinoblastoma: an open-label, multicentre, randomised trial. The Lancet Child & Adolescent Health 7:9, pages 613-620.
Crossref
Crossref
Jun Mao, Mingzhi Lu, Siduo Lu, Yiqiao Xing, Xuejiao Xu, Ying Chen, Huirong Xu, Wei Zuo, Jingwen Zhou & Wei Du. (2023) Retinoblastoma gene expression profiling based on bioinformatics analysis. BMC Medical Genomics 16:1.
Crossref
Crossref
YongZheng Wai, DhanyaMenon Radhakrishnan, Ganeshwara Lingam, Norhafizah Hamzah & Jamalia Rahmat. (2023) Intra-arterial chemotherapy for retinoblastoma: Experience from the pediatric ophthalmology referral center in Malaysia with literature review. Taiwan Journal of Ophthalmology 0:0, pages 0.
Crossref
Crossref
Jiakai Li, Chaohui Jing, Xuming Hua, Tingyi Liang, Jing Li, Peiquan Zhao & Xunda Ji. (2021) Outcome of salvage intra-arterial chemotherapy for recurrent retinoblastoma. Eye 36:11, pages 2106-2110.
Crossref
Crossref
Paula Schaiquevich, Jasmine H. Francis, María Belén Cancela, Angel Montero Carcaboso, Guillermo L. Chantada & David H. Abramson. (2022) Treatment of Retinoblastoma: What Is the Latest and What Is the Future. Frontiers in Oncology 12.
Crossref
Crossref
Yang Cao, Mi Zhou, Min Tian & Hong-bin Lv. (2022) The Safety and Effectiveness of Melphalan-Based Intra-Arterial Chemotherapy for Retinoblastoma: An Updated Single-Arm Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-11.
Crossref
Crossref
Xiang Gu, Minyue Xie, Renbing Jia & Shengfang Ge. (2021) Publication Trends of Research on Retinoblastoma During 2001–2021: A 20-Year Bibliometric Analysis. Frontiers in Medicine 8.
Crossref
Crossref
Armida W. M. Fabius, Milo van Hoefen Wijsard, Flora E. van Leeuwen & Annette C. Moll. (2021) Subsequent Malignant Neoplasms in Retinoblastoma Survivors. Cancers 13:6, pages 1200.
Crossref
Crossref
Vishal Raval, R. Christopher Bowen, Hansell Soto & Arun Singh. (2021) Chemotherapy for Retinoblastoma: Impact of Intravitreal Chemotherapy. Asia-Pacific Journal of Ophthalmology 10:2, pages 200-202.
Crossref
Crossref
Vishal Raval, Randy Christopher Bowen, Hansell Soto & Arun Singh. (2021) Intravenous Chemotherapy for Retinoblastoma in the Era of Intravitreal Chemotherapy: A Systematic Review. Ocular Oncology and Pathology 7:2, pages 142-148.
Crossref
Crossref
Petra Ketteler & Eva Biewald. 2021. Late Treatment Effects and Cancer Survivor Care in the Young. Late Treatment Effects and Cancer Survivor Care in the Young
279
286
.
Ida Russo, Christine Levy‐Gabriel, Axelle Dupont, Livia Lumbroso‐Le Rouic, Nathalie Cassoux, Laurence Desjardins, Anne‐Isabelle Bertozzi, Carole Coze, François Doz, Alexia Savignoni & Isabelle Aerts. (2020) Prospective phase II study of children affected by bilateral intraocular retinoblastoma with macular involvement of both eyes or in the only preserved eye. Macular tumor control, eye preservation rate, and visual outcome. Pediatric Blood & Cancer 68:1.
Crossref
Crossref
Tamaki Ueda, Yuhki Koga, Hiroshi Yoshikawa, Mika Tanabe, Kanako Yamana, Utako Oba, Kentaro Nakashima, Hiroaki Ono, Takuya Ichimura, Shunji Hasegawa, Wakako Kato, Tetsuko Kobayashi, Hideki Nakayama, Yasunari Sakai, Tadamasa Yoshitake, Saiji Ohga, Yoshinao Oda, Shigenobu Suzuki, Koh-Hei Sonoda & Shouichi Ohga. (2020) Survival and ocular preservation in a long-term cohort of Japanese patients with retinoblastoma. BMC Pediatrics 20:1.
Crossref
Crossref
Rossukon Kaewkhaw & Duangnate Rojanaporn. (2020) Retinoblastoma: Etiology, Modeling, and Treatment. Cancers 12:8, pages 2304.
Crossref
Crossref
Thomas W Link, Alejandro Santillan & Athos Patsalides. (2020) Intra-arterial neuroprotective therapy as an adjunct to endovascular intervention in acute ischemic stroke: A review of the literature and future directions. Interventional Neuroradiology 26:4, pages 405-415.
Crossref
Crossref
Lauren A. Dalvin, Zeynep Bas, Sameeksha Tadepalli, Raksha Rao, Sarangdev Vaidya, Richard Pacheco & Carol L. Shields. (2020) Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients. Journal of Pediatric Ophthalmology & Strabismus 57:4, pages 224-234.
Crossref
Crossref
David Ancona-Lezama, LaurenA Dalvin & CarolL Shields. (2020) Modern treatment of retinoblastoma: A 2020 review. Indian Journal of Ophthalmology 68:11, pages 2356.
Crossref
Crossref
Myron Yanoff & Joseph W. Sassani. 2020. Ocular Pathology. Ocular Pathology
726
759.e5
.
Krishnan Ravindran, Lauren A Dalvin, Jose S Pulido & Waleed Brinjikji. (2019) Intra-arterial chemotherapy for retinoblastoma: an updated systematic review and meta-analysis. Journal of NeuroInterventional Surgery 11:12, pages 1266-1272.
Crossref
Crossref
Alena Furdova & Juraj Sekac. 2019. Retinoblastoma - Past, Present and Future. Retinoblastoma - Past, Present and Future.
Francis L. Munier, Maja Beck-Popovic, Guillermo L. Chantada, David Cobrinik, Tero T. Kivelä, Dietmar Lohmann, Philippe Maeder, Annette C. Moll, Angel Montero Carcaboso, Alexandre Moulin, Paula Schaiquevich, Ciara Bergin, Paul J. Dyson, Susan Houghton, Francesco Puccinelli, Yvan Vial, Marie-Claire Gaillard & Christina Stathopoulos. (2019) Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. “Alive, with good vision and no comorbidity”. Progress in Retinal and Eye Research 73, pages 100764.
Crossref
Crossref
David H Abramson, Xunda Ji, Jasmine H Francis, Federica Catalanotti, Scott E Brodie & Larissa Habib. (2019) Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds. British Journal of Ophthalmology 103:4, pages 488-493.
Crossref
Crossref
Mary E. Kim, Sona Shah, Emily Zolfaghari, Rima Jubran, Mark W. Reid, Jonathan W. Kim & Jesse L. Berry. (2019) An Intraocular Pressure Predictive of High-risk Histopathologic Features in Group E Retinoblastoma Eyes. International Ophthalmology Clinics 59:2, pages 77-86.
Crossref
Crossref
Lauren A. Dalvin, David Ancona-Lezama, J. Antonio Lucio-Alvarez, Babak Masoomian, Pascal Jabbour & Carol L. Shields. (2018) Ophthalmic Vascular Events after Primary Unilateral Intra-arterial Chemotherapy for Retinoblastoma in Early and Recent Eras. Ophthalmology 125:11, pages 1803-1811.
Crossref
Crossref
Hayyam Kiratli, İrem Koç, Onur Inam, Ali Varan & Canan Akyüz. (2018) Retrospective analysis of primarily treated group D retinoblastoma. Graefe's Archive for Clinical and Experimental Ophthalmology 256:11, pages 2225-2231.
Crossref
Crossref
Amy C Schefler & Ryan S Kim. (2018) Recent advancements in the management of retinoblastoma and uveal melanoma. F1000Research 7, pages 476.
Crossref
Crossref
Jasmine H. Francis, Larissa A. Habib & David H. Abramson. (2017) Vitreous Disease in Retinoblastoma. Advances in Ophthalmology and Optometry 2:1, pages 177-195.
Crossref
Crossref